Xanthus Pharmaceuticals

Xanthus is a biopharmaceutical company.

Business Model:

Revenue: $0

Employees: 11-50

Rankings

Detailed Xanthus Pharmaceuticals Information

Xanthus Pharmaceuticals was acquired by Antisoma.
The acquisition happend on 2008-05-16.
Details of the transaction were not public

Acquirer

Geographic Data

Xanthus Pharmaceuticals headquarters map

Address:

City: Cambridge

State: Massachusetts

Zip:

Country: United States

Financial Info

Stage:

series b

Raised Last:

$25M

Raised Total:

$76M

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

Xanthus Pharmaceuticals Inc. operates as a biopharmaceutical company. It focuses on the discovery, development, acquisition, and commercialization of small-molecule therapeutics for the treatment of cancer and autoimmune disorders.

Contact Phone:

Contact Email:

Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
2/2003 Series A $0 HealthCare Ventures
Kestrel Venture Management
The Still River Fund
HealthCare Ventures
Kestrel Venture Management
The Still River Fund
12/2006 Series B $0 CDIB BioScience Ventures
CDP Capital Technology Ventures
GeneChem
Gimv
Hambrecht &a; Quist Capital Management
HealthCare Ventures
Kester Capital
Neomed Management
The Still River Fund
Yasuda Enterprise Development
CDIB BioScience Ventures
CDP Capital Technology Ventures
GeneChem
Gimv
Hambrecht &a; Quist Capital Management
HealthCare Ventures
Kester Capital
Neomed Management
The Still River Fund
Yasuda Enterprise Development
12/2003 Series B $0 CDIB BioScience Ventures
CDP Capital Technology Ventures
China Development Industrial Bank (CDIB)
GeneChem
Gimv
Hambrecht &a; Quist Capital Management
HealthCare Ventures
Kestrel Management
Oxford Bioscience Partners
The Still River Fund
Yasuda Enterprise Development
CDIB BioScience Ventures
CDP Capital Technology Ventures
China Development Industrial Bank (CDIB)
GeneChem
Gimv
Hambrecht &a; Quist Capital Management
HealthCare Ventures
Kestrel Management
Oxford Bioscience Partners
The Still River Fund
Yasuda Enterprise Development
12/2006 Series B 10 $25M CDIB BioScience Ventures
CDP Capital Technology Ventures
GeneChem
Gimv
Hambrecht &a; Quist Capital Management
HealthCare Ventures
Kester Capital
Neomed Management
The Still River Fund
Yasuda Enterprise Development
CDIB BioScience Ventures
CDP Capital Technology Ventures
GeneChem
Gimv
Hambrecht &a; Quist Capital Management
HealthCare Ventures
Kester Capital
Neomed Management
The Still River Fund
Yasuda Enterprise Development
12/2003 Series B 11 $30.8M CDIB BioScience Ventures
CDP Capital Technology Ventures
China Development Industrial Bank (CDIB)
GeneChem
Gimv
Hambrecht &a; Quist Capital Management
HealthCare Ventures
Kestrel Management
Oxford Bioscience Partners
The Still River Fund
Yasuda Enterprise Development
CDIB BioScience Ventures
CDP Capital Technology Ventures
China Development Industrial Bank (CDIB)
GeneChem
Gimv
Hambrecht &a; Quist Capital Management
HealthCare Ventures
Kestrel Management
Oxford Bioscience Partners
The Still River Fund
Yasuda Enterprise Development
2/2003 Series A 3 $20.4M HealthCare Ventures
Kestrel Venture Management
The Still River Fund
HealthCare Ventures
Kestrel Venture Management
The Still River Fund
Announced Date Name Price

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research